Breaking News

MedPharm Expands Testing Models to Target Coronavirus

Helps accelerate treatment development prior to clinical trials

By: Contract Pharma

Contract Pharma Staff

MedPharm has expanded its testing models to support pharmaceutical development programs targeting Coronavirus treatments. These models allow companies to assess therapeutic effectiveness in nasal, airway (bronchial) and deep lung (alveolar) epithelia against members of the Coronaviridae family. This work will help to de-risk development programs and screen drugs for therapeutic effectiveness to accelerate development prior to clinical trials.   These models are based on air liquid interface tiss...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters